CARERATING CARE Ratings Q4 FY25 results (Jan–Mar 2025) and concall
CARE Ratings delivered a robust performance in Q4 and FY25, driven by strong growth in both domestic and overseas ratings businesses, coupled with increased contributions and improved profitability from non-ratings verticals. Strategic initiatives like verticalized business development, technology adoption, and expansion into new areas such as IFSC and ESG ratings have yielded positive outcomes. The company remains focused on outperforming industry growth and leveraging operating efficiencies.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 117 | 96 | 110 |
| EBITDA | 56 | 30 | 47 |
| Net profit | 47 | 28 | 43 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
